跳至主要内容
临床试验/IRCT20140715018490N5
IRCT20140715018490N5已完成3 期

To evaluate effectiveness of Tanacetum parthenium (L) Sch. consumption on blood inflammatory and coagulating indexes

Vice chancellor for research, Fasa University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
Male

入选标准

  • age between20 and 60
  • negative hx of D.M
  • negative hx of major surgery(Under 6 months)
  • negative hx of HTN
  • negative hx of coagulopathy like hemophilia
  • negative hx of liver diseases
  • Satisfaction to participate in the scheme.
  • not use anticoaglant drugs and anti inflamatory drugs such as NSAIDs
  • Not to have bleeding disorders in GI system

排除标准

  • positive hx of coagulopathy like hemophilia
  • positive hx of HTN
  • positive hx of major surgery(Under 6 months)
  • positive hx of D.M
  • liver disease such as cirihosis or hepatitis
  • Age over 60 or under the age of 20
  • use anticoaglant drugs and anti inflamatory drugs such as NSAIDs
  • Dissatisfaction to participate in the scheme
  • To have bleeding disorders in GI system
  • possible complications

研究者

发起方
Vice chancellor for research, Fasa University of Medical Sciences

相似试验

Effectiveness of Tanacetum parthenium on... | 临床试验